Revenue (Quarterly) Chart

View Revenue (Quarterly) for SEER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 3.102M
March 31, 2026 2.793M
December 31, 2025 4.073M
September 30, 2025 4.121M
June 30, 2025 4.051M
March 31, 2025 4.205M
December 31, 2024 3.949M
September 30, 2024 4.032M
June 30, 2024 3.072M
March 31, 2024 3.066M
December 31, 2023 4.18M
September 30, 2023 4.162M
June 30, 2023 4.008M
March 31, 2023 4.053M
Date Value
December 31, 2022 3.86M
September 30, 2022 3.955M
June 30, 2022 3.621M
March 31, 2022 3.312M
December 31, 2021 3.032M
September 30, 2021 2.145M
June 30, 2021 1.334M
March 31, 2021 0.062M
December 31, 2020 0.336M
September 30, 2020 0.072M
June 30, 2020 0.071M
March 31, 2020 0.177M
December 31, 2019 0.058M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. 13.84M
Medpace Holdings, Inc. 707.33M
Avantor, Inc. 1.692B
Personalis, Inc. 22.36M
Adaptive Biotechnologies Corp. 71.55M